Tirzepatide Sale: Cifarma Rejects Drug Tax Proposal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The Chamber of the Chemical Pharmaceutical Industry (Cifarma), chaired by Hernán Streber, expressed its rejection of the bill promoted in the Chamber of Deputies, which proposes to tax with 5% the sales of the medicine tirzepatide. From the guild they warned that incorporating this tax burden represents a setback in the access to [...] The entry Sale of tirzepatide: Cifarma rejects proposed tax on the drug was first published in thirteen.
The Chamber of Pharmaceutical Chemical Industry (Cifarma), chaired by Hernán Streber, expressed its rejection of the bill promoted in the Chamber of Deputies, which proposes to tax with 5% the sales of the medicine tirzepatida. From the union they warned that incorporating this tax burden represents a setback in the access to [...] The Cifarma ticket rejects tax proposal to market tirzepatida in the country was first published in Unicanal.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
